Incidence, Genetic Characteristics, and Outcomes of Paediatric Cardiomyopathy in a National Cohort (2003–2025) - Top-Institutions - MDSpire

Incidence, Genetic Characteristics, and Outcomes of Paediatric Cardiomyopathy in a National Cohort (2003–2025)

  • By

  • Scott Kendall

  • Shannon Scott

  • Peter McClung

  • Joy McCance

  • Nawab Ali

  • Gillian Rea

  • William Wright

  • Jane Murray

  • Alison Muir

  • Martin Dempster

  • Terrence Prendiville

  • Pascal McKeown

  • Frank Casey

  • June 26, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Inherited Cardiac Conditions Clinic (ICCC)
    Inherited Cardiac Conditions Clinic (ICCC)

    Belfast, Northern Ireland

    Key Differentiators

    • Pediatric Cardiology

  • #2

    Paediatric Cardiology Centre
    Paediatric Cardiology Centre

    Belfast, Northern Ireland

    Key Differentiators

    • Pediatric Cardiology

  • #3

    NI Regional Molecular Diagnostics Service
    NI Regional Molecular Diagnostics Service

    Belfast, Northern Ireland

    Key Differentiators

    • Molecular Diagnostics

  • #4

    Manchester Centre for Genomic Medicine
    Manchester Centre for Genomic Medicine

    Manchester, England

    Key Differentiators

    • Genomic Medicine

  • #5

    Pediatric Cardiomyopathy Registry (PCMR)
    Pediatric Cardiomyopathy Registry (PCMR)

    Bethesda, Maryland

    Key Differentiators

    • Pediatric Cardiology

Original Source(s)

Incidence, Genetic Characteristics, and Outcomes of Paediatric Cardiomyopathy in a National Cohort (2003–2025)

  • by Scott Kendall, Shannon Scott, Peter McClung, Joy McCance, Nawab Ali, Gillian Rea, William Wright, Jane Murray, Alison Muir, Martin Dempster, Terrence Prendiville, Pascal McKeown, Frank Casey

  • June 26, 2026

Related Content

Early aortic valve intervention versus clinical surveillance in patients with asymptomatic severe aortic stenosis: a systematic review and meta-analysis

FDA Monthly Preview: Key July Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Surgical vs. trans-catheter aortic valve replacement in patients With bicuspid aortic valve stenosis